You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中關村(000931.SZ):與川大簽訂終止關於嗎啡類藥物全合成技術轉讓意向協議
格隆匯 11-17 16:39

格隆匯11月17日丨中關村(000931.SZ)公佈,2021年6月28日,公司與四川大學簽訂了《關於嗎啡類藥物全合成技術轉讓的意向書》(簡稱”《意向書》“)。2021年11月15日,公司與四川大學簽訂了《終止<關於嗎啡類藥物全合成技術轉讓的意向書>的協議書》。

公司表示,因麻醉藥立項審批及未來市場、產業落地等方面存在較大的不確定性,雙方達成一致,終止《意向書》,該協議的履行不存在損害公司及公司其他股東利益的情形,對公司當期及未來業績不會產生影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account